Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccination.
Lee HK, Hoechstetter MA, Buchner M, Pham TT, Huh JW, Müller K, Zange S, von Buttlar H, Girl P, Wölfel R, Brandmeier L, Pfeuffer L, Furth PA, Wendtner CM, Hennighausen L. Lee HK, et al. Among authors: wendtner cm. medRxiv [Preprint]. 2022 Sep 21:2022.09.21.22280205. doi: 10.1101/2022.09.21.22280205. medRxiv. 2022. Update in: Blood Adv. 2023 May 23;7(10):2214-2227. doi: 10.1182/bloodadvances.2022008445 PMID: 36172132 Free PMC article. Updated. Preprint.
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy.
Fürstenau M, Hopfinger G, Robrecht S, Fink AM, Al-Sawaf O, Langerbeins P, Cramer P, Tresckow JV, Maurer C, Kutsch N, Hoechstetter M, Dreyling M, Lange E, Kneba M, Stilgenbauer S, Döhner H, Hensel M, Kiehl MG, Jaeger U, Wendtner CM, Goede V, Fischer K, von Bergwelt-Baildon M, Eichhorst B, Hallek M, Theurich S. Fürstenau M, et al. Among authors: wendtner cm. Leukemia. 2020 Apr;34(4):1177-1181. doi: 10.1038/s41375-019-0630-6. Epub 2019 Nov 14. Leukemia. 2020. PMID: 31728057 No abstract available.
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
Schwarz T, Heiss K, Mahendran Y, Casilag F, Kurth F, Sander LE, Wendtner CM, Hoechstetter MA, Müller MA, Sekul R, Drosten C, Stadler V, Corman VM. Schwarz T, et al. Among authors: wendtner cm. Front Immunol. 2021 Mar 23;12:629185. doi: 10.3389/fimmu.2021.629185. eCollection 2021. Front Immunol. 2021. PMID: 33833755 Free PMC article. Clinical Trial.
Clinical and virological features of first human monkeypox cases in Germany.
Noe S, Zange S, Seilmaier M, Antwerpen MH, Fenzl T, Schneider J, Spinner CD, Bugert JJ, Wendtner CM, Wölfel R. Noe S, et al. Among authors: wendtner cm. Infection. 2023 Feb;51(1):265-270. doi: 10.1007/s15010-022-01874-z. Epub 2022 Jul 11. Infection. 2023. PMID: 35816222 Free PMC article.
Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination.
Lee HK, Hoechstetter MA, Buchner M, Pham TT, Huh JW, Müller K, Zange S, von Buttlar H, Girl P, Wölfel R, Brandmeier L, Pfeuffer L, Furth PA, Wendtner CM, Hennighausen L. Lee HK, et al. Among authors: wendtner cm. Blood Adv. 2023 May 23;7(10):2214-2227. doi: 10.1182/bloodadvances.2022008445. Blood Adv. 2023. PMID: 36630562 Free PMC article.
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression.
Ecker V, Brandmeier L, Stumpf M, Giansanti P, Moreira AV, Pfeuffer L, Fens MHAM, Lu J, Kuster B, Engleitner T, Heidegger S, Rad R, Ringshausen I, Zenz T, Wendtner CM, Müschen M, Jellusova J, Ruland J, Buchner M. Ecker V, et al. Among authors: wendtner cm. Cell Rep. 2023 Oct 31;42(10):113017. doi: 10.1016/j.celrep.2023.113017. Epub 2023 Oct 4. Cell Rep. 2023. PMID: 37792532 Free article.
Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations.
Cramer P, Tausch E, von Tresckow J, Giza A, Robrecht S, Schneider C, Fürstenau M, Langerbeins P, Al-Sawaf O, Pelzer BW, Fink AM, Fischer K, Wendtner CM, Eichhorst B, Kneba M, Stilgenbauer S, Hallek M. Cramer P, et al. Among authors: wendtner cm. Blood. 2021 Nov 11;138(19):1805-1816. doi: 10.1182/blood.2020010484. Blood. 2021. PMID: 34086865 Free PMC article. Clinical Trial.
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Tscherne A, Schwarz JH, Rohde C, Kupke A, Kalodimou G, Limpinsel L, Okba NMA, Bošnjak B, Sandrock I, Odak I, Halwe S, Sauerhering L, Brosinski K, Liangliang N, Duell E, Jany S, Freudenstein A, Schmidt J, Werner A, Gellhorn Serra M, Klüver M, Guggemos W, Seilmaier M, Wendtner CM, Förster R, Haagmans BL, Becker S, Sutter G, Volz A. Tscherne A, et al. Among authors: wendtner cm. Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):e2026207118. doi: 10.1073/pnas.2026207118. Proc Natl Acad Sci U S A. 2021. PMID: 34162739 Free PMC article.
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.
Staber PB, Jurczak W, Greil R, Vucinic V, Middeke JM, Montillo M, Munir T, Neumeister P, Schetelig J, Stilgenbauer S, Striebel F, Dirnberger-Hertweck M, Weirather J, Brugger W, Kelemen P, Wendtner CM, Woyach JA. Staber PB, et al. Among authors: wendtner cm. Leuk Lymphoma. 2021 Dec;62(14):3440-3451. doi: 10.1080/10428194.2021.1964020. Epub 2021 Aug 20. Leuk Lymphoma. 2021. PMID: 34414843 Clinical Trial.
Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older.
Simon F, Giza A, Robrecht S, Fink AM, Cramer P, von Tresckow J, Fürstenau M, Goede V, Tausch E, Schneider C, Stilgenbauer S, Wendtner CM, Eichhorst B, Fischer K, Hallek M, Al-Sawaf O. Simon F, et al. Among authors: wendtner cm. Leuk Lymphoma. 2022 Dec;63(14):3299-3306. doi: 10.1080/10428194.2022.2123223. Epub 2022 Sep 18. Leuk Lymphoma. 2022. PMID: 36120898
232 results